Analysis of the treatment responses in 55 patients revealed that CLB, KD, VPA, and TPM produced better efficacy in SCN1A variant-related epilepsy patients, LEV showed slight efficacy, and OXC and LTG were ineffective in controlling convulsions. This evidence concerns the gene SCN1A and epilepsy.